Quote:
Originally Posted by 7sins
Agree with both of you on COTY. We already have good insight into ER as IPAD validated market strength and increased guidance. LRCLY validated cosmetics. So I think behind the scenes sales are very strong. My two concerns are if any supply chain disruptions are disruptive to revenue and also the impact of China sales given their resurgence of covid or just in general due to delta last quarter. Guidance will be key here. Remember KKR and JAB have an ENOMOROUS number of shares sub $5. I fear everytime we get close to $10 they unload into the market, which is evident by the YTD chart. Anyways, it is still one of my biggest positions, I noted here trimming at 9.50 and then backing the truck back up when dipped below $8 recently.
I am waiting for this run up again to ER to then sell any calls with a strike higher than $10 into 2023 $7C and trim gains into cash. Will limit my upside but ITM calls here have proven to be better trades and I can put any fear away with more shares sold from KKR/JAB ~$10 but still have plenty upside. Just my .02.
|
are you still in any 2022s? my biggest position in coty is in jan 23 12c so if we get closer to 10 i might trim those and buy back later into something less otm. current delta on these is pretty bad so i wouldn't miss out on much gains with the way this stock has been acting. stocks that only start going up a few weeks before earnings then fall/stay flat for months after are so confusing to long lol